Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
Adobe
ADBE
KB Home
KBH
US Stock MarketDetailed Quotes
IDYA IDEAYA Biosciences
- 24.930
- -0.230-0.91%
Close Dec 30 16:00 ET
- 25.250
- +0.320+1.28%
Post 20:01 ET
2.15BMarket Cap-10.70P/E (TTM)
25.080High24.200Low790.52KVolume24.760Open25.160Pre Close19.64MTurnover0.92%Turnover RatioLossP/E (Static)86.43MShares47.73552wk High1.83P/B2.13BFloat Cap24.20052wk Low--Dividend TTM85.54MShs Float47.735Historical High--Div YieldTTM3.50%Amplitude2.950Historical Low24.840Avg Price1Lot Size
About IDEAYA Biosciences Company
IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.
Company Profile
SymbolIDYA
Company NameIDEAYA Biosciences
Listing DateMay 23, 2019
Issue Price10.00
Founded2015
CEOMr. Yujiro S. Hata
MarketNASDAQ
Employees124
Fiscal Year Ends12-31
Address5000 Shoreline Court,Suite 300
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-443-6209
Websitehttp://www.ideayabio.com
Company Executives
- Name
- Position
- Salary
- Yujiro S. Hata
- Director, President and Chief Executive Officer
- 6.00M
- Dr. Darrin M. Beaupre, M.D.
- Chief Medical Officer
- 1.81M
- Dr. Michael Anthony White, PhD
- Chief Scientific Officer
- 2.76M
- Andres Ruiz Briseno
- Principal Financial Officer, Principal Accounting Officer, Senior Vice President, Head of Finance and Investor Relations
- 1.41M
- Dr. Terry Rosen, PhD
- Chairman of the Board
- 369.52K
- Scott W. Morrison
- Independent Director
- 364.52K
- Malcolm Garret Hampton, PhD
- Independent Director
- 349.52K
- Dr. Susan L. Kelley, M.D.
- Independent Director
- 349.52K
- Dr. Catherine J. Mackey, PhD
- Independent Director
- 350.52K
- Wendy L. Yarno, M.B.A.
- Independent Director
- 358.02K
- Dr. Jeffrey Stein, PhD
- Independent Director
- 363.02K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.